Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- SCON -15.6%, DGLY -12%, APHB -3.2%, AUXO -2.8%, FDS -1.2%, RAVN -1%
Other news:
- CYRX -45.4% (to offer shares of common stock in an underwritten public offering)
- STAF -8.6% (reject buy-out offer from Jackson Investment Group of $1.10 per share)
- CEMP -6.9% (withdraws marketing authorization application seeking European Medicines Agency approval of oral capsule and intravenous formulations of solithromycin)
- TCON -4.8% (files for up to 3,231,515 share common stock offering by Aspire Capital; announces that TRC694 preclinical data will be presented at the upcoming American Association for Cancer Research annual meeting to be held April 1-5 in Washington, D.C.)
- EVH -4.2% (prices secondary offering by selling shareholders of 7.5 mln shares of common stock)
- INAP -3.7% ( filed for approx 27.2 mln share common stock offering by holders)
- SNAP -2% (Facebook (FB) launches competing 'camera effects' and 'stories')
- ATH -1.4% (announces secondary offering of 25 mln Class A common shares by certain shareholders)
- LYG -1.2% (continued weakness following yesterday's downgrade)
- ERIC -1.2% (presents new business strategy to improve profitability; Sees Q1 write down of assets with an estimated impact on operating income of SEK3-4 bln)
Analyst comments:
- FIS -1.1% (downgraded to Neutral at Goldman)